ArticleJournal of cardiovascular development and disease2026
Pleural Effusion After Endoscopic-Assisted, Minimally Invasive Off-Pump Bypass Grafting.
Article in Journal of cardiovascular development and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postoperative pleural effusion (PE) is a common finding after endoscopic-assisted, minimally invasive coronary bypass surgery (Endo-CAB). This study evaluated its postoperative course, defined a threshold for clinically significant PE, and identified associated risk factors. Between May 2021 and January 2026, 727 patients were retrospectively analyzed. A total of 3141 postoperative chest X-rays obtained during hospitalization and follow-up were reviewed to quantify PE. Clinically significant PE was defined as ≥25% on radiographic assessment. Baseline characteristics and postoperative outcomes were analyzed, and logistic regression was used to identify independent risk factors. All patients received oral diuretics for two weeks after discharge as standard protocol. PE occurred in 86.1% of patients, typically developing within the first two postoperative days, with a median maximum of 13% [5-21%]. By the third postoperative week, PE had resolved to 0% [0-0%] in most cases. Adjustment of diuretic therapy was required in 18.3%, while 5.1% underwent thoracocentesis. Clinically significant PE occurred in 15.4% and was associated with longer hospital stay and increased blood transfusion rates. Independent risk factors included age, body mass index, continuation of dual antiplatelet therapy, and blood transfusion. Overall, PE is frequent but usually self-limiting after Endo-CAB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.